Mechanisms and mediators of inflammation: Potential models for skin rejection and targeted therapy in vascularized composite allotransplantation

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Hautz, Theresa ^a   Wolfram, Dolores ^a   Grahammer, Johanna ^a   Starzl, Ravi ^b   Krapf, Christoph ^a   Pratschke, Johann ^a   Lee, W P Andrew ^c   Brandacher, Gerald ^c   Schneeberger, Stefan ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Carnegie Mellon University ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN; INTEGRIN; SELECTIN; AUTACOID;

CELL INTERACTION; CELL MIGRATION; DERMATITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SKIN ALLOGRAFT; T LYMPHOCYTE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; IMMUNOLOGY; INFLAMMATION; SKIN; SKIN TRANSPLANTATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SKIN; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84867389239     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/757310     Document Type: Review

References (121)

1. Petruzzo P., Lanzetta M., Dubernard J. M., Landin L., Cavadas P., Margreiter R., Schneeberger S., Breidenbach W., Kaufman C., Jablecki J., Schuind F., Dumontier C., The international registry on hand and composite tissue transplantation. Transplantation 2010 90 12 1590 1594 2-s2.0-78650806321 10.1097/TP.0b013e3181ff1472
2. Jose M., Calcineurin inhibitors in renal transplantation: adverse effects. Nephrology 2007 12 supplement 1 S66 S74 2-s2.0-33846976448 10.1111/j.1440-1797.2007.00731.x
3. Buell J. F., Gross T. G., Woodle E. S., Malignancy after transplantation. Transplantation 2005 80 2, supplement S254 S264 2-s2.0-27644474482 10.1097/01.tp.0000186382.81130.ba
4. Bonatti H., Brandacher G., Margreiter R., Schneeberger S., Infectious complications in three double hand recipients: experience from a single center. Transplantation Proceedings 2009 41 2 517 520 2-s2.0-62849108249 10.1016/j.transproceed.2009.01.014
5. Hautz T., Brandacher G., Engelhardt T. O., How reconstructive transplantation is different from organ transplantationand how it is not. Transplantation Proceedings 2011 43 9 3504 3511
6. Schneeberger S., Lucchina S., Lanzetta M., Brandacher G., Bösmüller C., Steurer W., Baldanti F., Dezza C., Margreiter R., Bonatti H., Cytomegalovirus-related complications in human hand transplantation. Transplantation 2005 80 4 441 447 2-s2.0-23944448047 10.1097/01.tp.0000168454. 68139.0a
7. Hautz T., Zelger B., Grahammer J., Krapf C., Amberger A., Brandacher G., Landin L., Müller H., Schön M. P., Cavadas P., Lee A. W. P., Pratschke J., Margreiter R., Schneeberger S., Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. American Journal of Transplantation 2010 10 5 1200 1209 2-s2.0-77951227495 10.1111/j.1600-6143.2010. 03075.x
8. Kanitakis J., Jullien D., Petruzzo P., Hakim N., Claudy A., Revillard J. P., Owen E., Dubernard J. M., Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation 2003 76 4 688 693 2-s2.0-0041835978 10.1097/01.TP.0000079458.81970.9A
9. Hautz T., Zelger B., Brandacher G., Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts. Transplant International 2012 25 1 56 63
10. Kanitakis J., The challenge of dermatopathological diagnosis of composite tissue allograft rejection: a review. Journal of Cutaneous Pathology 2008 35 8 738 744 2-s2.0-58149198248 10.1111/j.1600-0560.2007.00889.x
11. Schön M. P., Zollner T. M., Boehncke W. H., The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders. Journal of Investigative Dermatology 2003 121 5 951 962 2-s2.0-0242490176 10.1046/j.1523-1747.2003.12563.x
12. Wood K. J., Goto R., Mechanisms of rejection: current perspectives. Transplantation 2011 93 1 1 10
13. Baddoura F. K., Nasr I. W., Wrobel B., Li Q., Ruddle N. H., Lakkis F. G., Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection. American Journal of Transplantation 2005 5 3 510 516 2-s2.0-14644435067 10.1111/j.1600-6143.2004.00714.x
14. Carragher D. M., Rangel-Moreno J., Randall T. D., Ectopic lymphoid tissues and local immunity. Seminars in Immunology 2008 20 1 26 42 2-s2.0-39649083585 10.1016/j.smim.2007.12.004
15. Thaunat O., Nicoletti A., Lymphoid neogenesis in chronic rejection. Current Opinion in Organ Transplantation 2008 13 1 16 19 2-s2.0-38149031779 10.1097/MOT.0b013e3282f3df15
16. von Andrian U. H., Mackay C. R., T-cell function and migration: two sides of the same coin. The New England Journal of Medicine 2000 343 14 1020 1034 2-s2.0-0034609968 10.1056/NEJM200010053431407
17. Bevilacqua M., Butcher E., Furie B., Furie B., Gallatin M., Gimbrone M., Harlan J., Kishimoto K., Lasky L., McEver R., Paulson J., Rosen S., Seed B., Siegelman M., Springer T., Stoolman L., Tedder T., Varki A., Wagner D., Selectins: a family of adhesion receptors. Cell 1991 67 2 233 2-s2.0-0026042494 10.1016/0092-8674(91)90174-W
18. Pudelko M., Bull J., Kunz H., Chemical and chemoenzymatic synthesis of glycopeptide selectin ligands containing sialyl lewis X structures. ChemBioChem 2010 11 7 904 930 2-s2.0-77951761659 10.1002/cbic.201000029
19. Bevilacqua M. P., Pober J. S., Mendrick D. L., Cotran R. S., Gimbrone M. A. Jr., Identification of an inducible endothelial-leukocyte adhesion molecule. Proceedings of the National Academy of Sciences of the United States of America 1987 84 24 9238 9242 2-s2.0-0023488843
20. Bonfanti R., Furie B. C., Furie B., Wagner D. D., PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989 73 5 1109 1112 2-s2.0-0024580737
21. Patel K. D., Zimmerman G. A., Prescott S. M., McEver R. P., McIntyre T. M., Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. Journal of Cell Biology 1991 112 4 749 759 2-s2.0-0026059929
22. Picker L. J., Butcher E. C., Physiological and molecular mechanisms of lymphocyte homing. Annual Review of Immunology 1992 10 561 591 2-s2.0-0026642637
23. Streeter P. R., Rouse B. T., Butcher E. C., Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. Journal of Cell Biology 1988 107 5 1853 1862 2-s2.0-0024109988
24. Hirata T., Furie B. C., Furie B., P-, E-, and L-selectin mediate migration of activated CD8+ T lymphocytes into inflamed skin. Journal of Immunology 2002 169 8 4307 4313 2-s2.0-0037108361
25. Bhushan M., Bleiker T. O., Ballsdon A. E., Allen M. H., Sopwith M., Robinson M. K., Clarke C., Weller R. P. J. B., Graham-Brown R. A. C., Keefe M., Barker J. N. W. N., Griffiths C. E. M., Anti-e-selectin is ineffective in the treatment of psoriasis: a randomized trial. British Journal of Dermatology 2002 146 5 824 831 2-s2.0-0036105980 10.1046/j.1365-2133.2002.04743.x
26. Friedrich M., Bock D., Philipp S., Ludwig N., Sabat R., Wolk K., Schroeter-Maas S., Aydt E., Kang S., Dam T. N., Zahlten R., Sterry W., Wolff G., Pan-selectin antagonism improves psoriasis manifestation in mice and man. Archives of Dermatological Research 2006 297 8 345 351 2-s2.0-31344431570 10.1007/s00403-005-0626-0
27. Phillips M. L., Nudelman E., Gaeta F. C. A., Perez M., Singhal A. K., Hakomori S. I., Paulson J. C., ELAM-I mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Le. Science 1990 250 4984 1130 1132 2-s2.0-0025572709
28. Lewinsohn D. M., Bargatze R. F., Butcher E. C., Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. Journal of Immunology 1987 138 12 4313 4321 2-s2.0-0023179057
29. Springer T. A., Adhesion receptors of the immune system. Nature 1990 346 6283 425 434 2-s2.0-0025182959 10.1038/346425a0
30. Dustin M. L., Singer K. H., Tuck D. T., Springer T. A., Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). Journal of Experimental Medicine 1988 167 4 1323 1340 2-s2.0-0023894291
31. Staunton D. E., Dustin M. L., Springer T. A., Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989 339 6219 61 64 2-s2.0-0024592732
32. Carlos T. M., Schwartz B. R., Kovach N. L., Yee E., Rosso M., Osborn L., Chi-Rosso G., Newman B., Lobb R., Harlan J. M., Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 1990 76 5 965 970 2-s2.0-0025179082
33. Maula S. M., Salminen T., Kaitaniemi S., Nymalm Y., Smith D. J., Jalkanen S., Carbohydrates located on the top of the cap contribute to the adhesive and enzymatic functions of vascular adhesion protein-1. European Journal of Immunology 2005 35 9 2718 2727 2-s2.0-23644462705 10.1002/eji.200526351
34. Springer T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 2 301 314 2-s2.0-0027982876 10.1016/0092-8674(94)90337-9
35. Alon R., Feigelson S., From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Seminars in Immunology 2002 14 2 93 104 2-s2.0-0036024087 10.1006/smim.2001.0346
36. Shamri R., Grabovsky V., Gauguet J. M., Feigelson S., Manevich E., Kolanus W., Robinson M. K., Staunton D. E., Von Andrian U. H., Alon R., Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nature Immunology 2005 6 5 497 506 2-s2.0-18244364123 10.1038/ni1194
37. Campbell J. J., Hedrick J., Zlotnik A., Siani M. A., Thompson D. A., Butcher E. C., Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 1998 279 5349 381 384 2-s2.0-0032536046 10.1126/science.279. 5349.381
38. Ludwig R. J., Zollner T. M., Santoso S., Hardt K., Gille J., Baatz H., Johann P. S., Pfeffer J., Radeke H. H., Schön M. P., Kaufmann R., Boehncke W. H., Podda M., Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. Journal of Investigative Dermatology 2005 125 5 969 976 2-s2.0-33644795491 10.1111/j.0022-202X.2005.23912.x
39. Iezzi G., Karjalainen K., Lanzavecchia A., The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998 8 1 89 95 2-s2.0-0031884839 10.1016/S1074-7613(00)80461-6
40. Iezzi G., Scotet E., Scheidegger D., Lanzavecchia A., The interplay between the duration of TCR and cytokine signaling determines T cell polarization. European Journal of Immunology 1999 29 12 4092 4101
41. Montoya M. C., Sancho D., Bonello G., Collette Y., Langlet C., He H. T., Aparicio P., Alcover A., Olive D., Sánchez-Madrid F., Role of ICAM-3 in the initial interaction of T lymphocytes and APCs. Nature Immunology 2002 3 2 159 168 2-s2.0-0036172558 10.1038/ni753
42. Hauss P., Selz F., Cavazzana-Calvo M., Fischer A., Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells. European Journal of Immunology 1995 25 8 2285 2294 2-s2.0-0029131483 10.1002/eji.1830250826
43. Damle N. K., Klussman K., Aruffo A., Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells. Journal of Immunology 1992 148 3 665 671 2-s2.0-0026571222
44. Bishop G. A., Hostager B. S., B lymphocyte activation by contact-mediated interactions with T lymphocytes. Current Opinion in Immunology 2001 13 3 278 285 2-s2.0-0035367804 10.1016/S0952-7915(00)00216-8
45. Kruman I. I., Ramiya V., Bondada S., A role for T cell CD4 in contact mediated T dependent B cell activation. Cellular Immunology 1996 173 2 236 245 2-s2.0-0030296396 10.1006/cimm.1996.0273
46. Montoya M. C., Sancho D., Vicente-Manzanares M., Sánchez-Madrid F., Cell adhesion and polarity during immune interactions. Immunological Reviews 2002 186 68 82 2-s2.0-0036696402 10.1034/j.1600-065X.2002.18607.x
47. Robert C., Kupper T. S., Inflammatory skin diseases, T cells, and immune surveillance. The New England Journal of Medicine 1999 341 24 1817 1828 2-s2.0-0345504168 10.1056/NEJM199912093412407
48. Schön M. P., Boehncke W. H., Psoriasis. The New England Journal of Medicine 2005 352 18 1899 1912 2-s2.0-17944364473 10.1056/NEJMra041320
49. Fuhlbrigge R. C., Kieffer J. D., Armerding D., Kupper T. S., Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997 389 6654 978 981 2-s2.0-1842413033 10.1038/40166
50. Kunstfeld R., Lechleitner S., Gröger M., Wolff K., Petzelbauer P., HECA-452+ T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. Journal of Investigative Dermatology 1997 108 3 343 348 2-s2.0-0031059388
51. Eedy D. J., Burrows D., Bridges J. M., Jones F. G. C., Clearance of severe psoriasis after allogenic bone marrow transplantation. British Medical Journal 1990 300 6729 908 2-s2.0-0025233606
52. Gardembas-Pain M., Ifrah N., Foussard C., Boasson M., Saint Andre J. P., Verret J. L., Psoriasis after allogeneic bone marrow transplantation. Archives of Dermatology 1990 126 11 1523 2-s2.0-0025086283 10.1001/archderm.126.11.1523
53. Berth-Jones J., The use of ciclosporin in psoriasis. Journal of Dermatological Treatment 2005 16 5-6 258 277 2-s2.0-31644442734 10.1080/09546630500423914
54. Gottlieb S. L., Gilleaudeau P., Johnson R., Estes L., Woodworth T. G., Gottlieb A. B., Krueger J. G., Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine 1995 1 5 442 447 2-s2.0-0028990380 10.1038/nm0595-442
55. Smith C. H., Barker J. N. W. N., Cell trafficking and role of adhesion molecules in psoriasis. Clinics in Dermatology 1995 13 2 151 160 2-s2.0-0028948629 10.1016/0738-081X(95)93821-5
56. Schön M. P., Ludwig R. J., Lymphocyte trafficking to inflamed skinmolecular mechanisms and implications for therapeutic target molecules. Expert Opinion on Therapeutic Targets 2005 9 2 225 243 2-s2.0-18144417512 10.1517/14728222.9.2.225
57. Zollner T. M., Asadullah K., Schön M. P., Targeting leukocyte trafficking to inflamed skinstill an attractive therapeutic approach? Experimental Dermatology 2007 16 1 1 12 2-s2.0-33845426318 10.1111/j.1600-0625. 2006.00503.x
58. Lebwohl M., Tyring S. K., Hamilton T. K., Toth D., Glazer S., Tawfik N. H., Walicke P., Dummer W., Wang X., Garovoy M. R., Pariser D., A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. The New England Journal of Medicine 2003 349 21 2004 2013 2-s2.0-0345107256 10.1056/NEJMoa030002
59. Schön M. P., Krahn T., Schön M., Rodriguez M. L., Antonicek H., Schultz J. E., Ludwig R. J., Zollner T. M., Bischoff E., Bremm K. D., Schramm M., Henninger K., Kaufmann R., Gollnick H. P. M., Parker C. M., Boehncke W. H., Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nature Medicine 2002 8 4 366 372 2-s2.0-0036117531 10.1038/nm0402-366
60. Birnbaum Y., Patterson M., Kloner R. A., The effect of CY1503, a sialyl lewis(x) analog blocker of the selectin adhesion molecules, on infarct size and 'no-reflow' in the rabbit model of acute myocardial infarction/reperfusion. Journal of Molecular and Cellular Cardiology 1997 29 8 2013 2025 2-s2.0-0031214933 10.1006/jmcc.1997.0393
61. Ikegami-Kuzuhara A., Yoshinaka T., Ohmoto H., Inoue Y., Saito T., Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis. British Journal of Pharmacology 2001 134 7 1498 1504 2-s2.0-0035210705
62. Abraham W. M., Ahmed A., Sabater J. R., Lauredo I. T., Botvinnikova Y., Bjercke R. J., Hu X., Mitch Revelle B., Kogan T. P., Scott I. L., Dixon R. A. F., Yeh E. T. H., Beck P. J., Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. American Journal of Respiratory and Critical Care Medicine 1999 159 4, part 1 1205 1214 2-s2.0-0032905458
63. Miyashiro M., Furuya S., Sugita T., A high-throughput screening system for α 1-3 fucosyltransferase-VII inhibitor utilizing scintillation proximity assay. Analytical Biochemistry 2005 338 1 168 170 2-s2.0-13644270326 10.1016/j.ab.2004.11.028
64. van Duijnhoven M. W. F., de Jong E. M. G. J., Gerritsen W. J., Pasch M. C., van de Kerkhof P. C. M., Alefacept modifies long-term disease severity and improves the response to other treatments. European Journal of Dermatology 2005 15 5 366 373 2-s2.0-25144468867
65. Jaeschke H., Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. American Journal of Physiology 2003 284 1 G15 G26 2-s2.0-0037229864
66. Jang H. R., Rabb H., The innate immune response in ischemic acute kidney injury. Clinical Immunology 2009 130 1 41 50 2-s2.0-57149084452 10.1016/j.clim.2008.08.016
67. Fondevila C., Busuttil R. W., Kupiec-Weglinski J. W., Hepatic ischemia/reperfusion injurya fresh look. Experimental and Molecular Pathology 2003 74 2 86 93 2-s2.0-0037387986 10.1016/S0014-4800(03)00008-X
68. Confi A., Scala S., D'Agostino P., Alimenti E., Morelli D., Andria B., Tammaro A., Attanasio C., Della Ragione F., Scuderi V., Fabbrini F., D'Esposito M., Di Florio E., Nitsch L., Calise F., Faiella A., Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation. Liver Transplantation 2007 13 1 99 113 2-s2.0-33846243808 10.1002/lt.20960
69. Garcia-Criado F. J., Toledo-Pereyra L. H., Lopez-Neblina F., Phillips M. L., Paez-Rollys A., Misawa K., Role of P-selectin in total hepatic ischemia and reperfusion. Journal of the American College of Surgeons 1995 181 4 327 334 2-s2.0-0029131911
70. Dulkanchainun T. S., Goss J. A., Imagawa D. K., Shaw G. D., Anselmo D. M., Kaldas F., Wang T., Zhao D., Busuttil A. A., Kato H., Murray N. G. B., Kupiec-Weglinski J. W., Busuttil R. W., Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1. Annals of Surgery 1998 227 6 832 840 2-s2.0-0032463409 10.1097/00000658- 199806000-00006
71. Busuttil R. W., Lipshutz G. S., Kupiec-Weglinski J. W., Ponthieux S., Gjertson D. W., Cheadle C., Watkins T., Ehrlich E., Katz E., Squiers E. C., Rabb H., Hemmerich S., RPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. American Journal of Transplantation 2011 11 4 786 797 2-s2.0-79953244190 10.1111/j.1600-6143.2011.03441.x
72. Petzelbauer P., Zacharowski P. A., Miyazaki Y., Friedl P., Wickenhauser G., Castellino F. J., Gröger M., Wolff K., Zacharowski K., The fibrin-derived peptide B β 15-42 protects the myocardium against ischemia-reperfusion injury. Nature Medicine 2005 11 3 298 304 2-s2.0-16244367746 10.1038/nm1198
73. Atar D., Petzelbauer P., Schwitter J., Huber K., Rensing B., Kasprzak J. D., Butter C., Grip L., Hansen P. R., Süselbeck T., Clemmensen P. M., Marin-Galiano M., Geudelin B., Buser P. T., Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. Journal of the American College of Cardiology 2009 53 8 720 729 2-s2.0-60049083078 10.1016/j.jacc.2008. 12.017
74. Luster A. D., Alon R., von Andrian U. H., Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunology 2005 6 12 1182 1190 2-s2.0-30044447736 10.1038/ni1275
75. Setoguchi K., Schenk A. D., Ishii D., Hattori Y., Baldwin W. M., Tanabe K., Fairchild R. L., LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. American Journal of Transplantation 2011 11 5 923 935 2-s2.0-79955544000 10.1111/j.1600-6143.2011.03492.x
76. Corbascio M., Ekstrand H., Österholm C., Qi Z., Simanaitis M., Larsen C. P., Pearson T. C., Riesbeck K., Ekberg H., CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. Transplant Immunology 2002 10 1 55 61 2-s2.0-0036023131 10.1016/S0966-3274(02)00014-X
77. Badell I. R., Russell M. C., Thompson P. W., Turner A. P., Weaver T. A., Robertson J. M., Avila J. G., Cano J. A., Johnson B. E., Song M., Leopardi F. V., Swygert S., Strobert E. A., Ford M. L., Kirk A. D., Larsen C. P., LFA-1specific therapy prolongs allograft survival in rhesus macaques. The Journal of Clinical Investigation 2010 120 12 4520 4531 2-s2.0-78649835002 10.1172/JCI43895
78. Vincenti F., Mendez R., Pescovitz M., Rajagopalan P. R., Wilkinson A. H., Butt K., Laskow D., Slakey D. P., Lorber M. I., Garg J. P., Garovoy M., A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. American Journal of Transplantation 2007 7 7 1770 1777 2-s2.0-34250202520 10.1111/j.1600-6143.2007. 01845.x
79. Lunsford K. E., Barbas A. S., Brennan T. V., Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. Current Opinion in Organ Transplantation 2011 16 4 390 397 2-s2.0-79958047019 10.1097/MOT.0b013e328348b420
80. Langer R., Wang M., Stepkowski S. M., Hancock W. W., Han R., Li P., Feng L., Kirken R. A., Berens K. L., Dupre B., Podder H., Dixon R. A. F., Kahan B. D., Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines. Journal of the American Society of Nephrology 2004 15 11 2893 2901 2-s2.0-16644369039 10.1097/01.ASN.0000142425.23036.AC
81. Bonecchi R., Sozzani S., Stine J. T., Luini W., D'Amico G., Allavena P., Chantry D., Mantovani A., Divergent effects of interleukin-4 and interferon- γ on macrophage- derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998 92 8 2668 2671 2-s2.0-0032532054
82. Sanz M. J., Kubes P., Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking. European Journal of Immunology 2012 42 2 278 283
83. Hancock W. W., Lu B., Gao W., Csizmadia V., Faia K., King J. A., Smiley S. T., Ling M., Gerard N. P., Gerard C., Requirement of the chemokine receptor CXCR3 for acute allograft rejection. Journal of Experimental Medicine 2000 192 10 1515 1520 2-s2.0-0034694024 10.1084/jem.192.10.1515
84. Gao W., Topham P. S., King J. A., Smiley S. T., Csizmadia V., Lu B., Gerard C. J., Hancock W. W., Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. The Journal of Clinical Investigation 2000 105 1 35 44 2-s2.0-0033987396
85. Horuk R., Clayberger C., Krensky A. M., Wang Z., Gröne H. J., Weber C., Weber K. S. C., Nelson P. J., May K., Rosser M., Dunning L., Liang M., Buckman B., Ghannam A., Ng H. P., Islam I., Bauman J. G., Wei G. P., Monahan S., Xu W., Snider R. M., Morrissey M. M., Hesselgesser J., Perez H. D., A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. The Journal of Biological Chemistry 2001 276 6 4199 4204 2-s2.0-0035830871 10.1074/jbc.M007457200
86. Nelson P. J., Krensky A. M., Chemokines and allograft rejection: narrowing the list of suspects. Transplantation 2001 72 7 1195 1197 2-s2.0-0035886033
87. Sallusto F., Lanzavecchia A., Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunological Reviews 2000 177 134 140 2-s2.0-0033658153
88. Lo D. J., Weaver T. A., Kleiner D. E., Mannon R. B., Jacobson L. M., Becker B. N., Swanson S. J., Hale D. A., Kirk A. D., Chemokines and their receptors in human renal allotransplantation. Transplantation 2011 91 1 70 77 2-s2.0-78751654770 10.1097/TP.0b013e3181fe12fc
89. Belperio J. A., Burdick M. D., Keane M. P., Xue Y. Y., Lynch J. P., Daugherty B. L., Kunkel S. L., Strieter R. M., The role of the CC chemokine, RANTES, in acute lung allograft rejection. Journal of Immunology 2000 165 1 461 472 2-s2.0-0034235699
90. Yang L., Liu Y. F., Wu G., Zhang J. L., Wang F. S., Fu D. Z., Zhao G. H., Li T. M., Blocking the CC chemokine receptor 5 pathway by antisense peptide nucleic acid prolongs islet allograft survival. Transplantation Proceedings 2007 39 1 185 190 2-s2.0-33846631304 10.1016/j.transproceed.2006.10.193
91. Jiankuo M., Xingbing W., Baojun H., Xiongwin W., Zhuoya L., Ping X., Yong X., Anting L., Chunsong H., Feili G., Jinquan T., Peptide nucleic acid antisense prolongs skin allograft survival by means of blockade of CXCR3 expression directing T cells into graft. Journal of Immunology 2003 170 3 1556 1565 2-s2.0-0037309226
92. Li B., Xu W., Xu L., Jiang Z., Wen Z., Li K., Xiong S., I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft. Cellular Immunology 2010 260 2 83 91 2-s2.0-71349083174 10.1016/j.cellimm.2009.09.004
93. Solomon M. F., Kuziel W. A., Mann D. A., Simeonovic C. J., The role of chemokines and their receptors in the rejection of pig islet tissue xenografts. Xenotransplantation 2003 10 2 164 177 2-s2.0-0042367675 10.1034/j.1399-3089. 2003.01146.x
94. Fiorina P., Jurewicz M., Vergani A., Petrelli A., Carvello M., D'Addio F., Godwin J. G., Law K., Wu E., Tian Z., Thoma G., Kovarik J., La Rosa S., Capella C., Rodig S., Zerwes H. G., Sayegh M. H., Abdi R., Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1. Journal of Immunology 2011 186 1 121 131 2-s2.0-79251536176 10.4049/jimmunol.1000799
95. Saint-Mezard P., Rosieres A., Krasteva M., Berard F., Dubois B., Kaiserlian D., Nicolas J. F., Allergic contact dermatitis. European Journal of Dermatology 2004 14 5 284 295 2-s2.0-4544259671
96. Saint-Mezard P., Bérard F., Dubois B., Kaiserlian D., Nicolas J. F., The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. European Journal of Dermatology 2004 14 3 131 138 2-s2.0-2942534378
97. Watanabe H., Unger M., Tuvel B., Wang B., Sauder D. N., Contact hypersensitivity: the mechanism of immune responses and T cell balance. Journal of Interferon and Cytokine Research 2002 22 4 407 412 2-s2.0-0036263787 10.1089/10799900252952181
98. Pastore S., Mascia F., Mariotti F., Dattilo C., Girolomoni G., Chemokine networks in inflammatory skin diseases. European Journal of Dermatology 2004 14 4 203 208 2-s2.0-3543077154
99. Riis J. L., Johansen C., Vestergaard C., Bech R., Kragballe K., Iversen L., Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Experimental Dermatology 2011 20 10 789 794 2-s2.0-79959548723 10.1111/j.1600-0625.2011.01323.x
100. Moed H., Boorsma D. M., Tensen C. P., Flier J., Jonker M. J., Stoof T. J., von Blomberg B. M. E., Bruynzeel D. P., Scheper R. J., Rustemeyer T., Gibbs S., Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory. Journal of Pathology 2004 204 1 39 46 2-s2.0-4544369006 10.1002/path.1619
101. Gunther C., Carballido-Perrig N., Kaesler S., Carballido J. M., Biedermann T., CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells. Journal of Investigative Dermatology 2012 132 3, part 1 626 634
102. Chen S. C., de Groot M., Kinsley D., Laverty M., McClanahan T., Arreaza M., Gustafson E. L., Teunissen M. B. M., De Rie M. A., Fine J. S., Kraan M., Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions. Archives of Dermatological Research 2010 302 2 113 123 2-s2.0-77449145700 10.1007/s00403-009-0966-2
103. Hillyer P., Mordelet E., Flynn G., Male D., Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clinical and Experimental Immunology 2003 134 3 431 441 2-s2.0-0346121316 10.1111/j.1365-2249.2003.02323.x
104. Mitsui G., Mitsui K., Hirano T., Ohara O., Kato M., Niwano Y., Kinetic profiles of sequential gene expressions for chemokines in mice with contact hypersensitivity. Immunology Letters 2003 86 2 191 197 2-s2.0-0037417157 10.1016/S0165-2478(03)00017-8
105. Watanabe H., Gaide O., Pétrilli V., Martinon F., Contassot E., Roques S., Kummer J. A., Tschopp J., French L. E., Activation of the IL-1 β -processing inflammasome is involved in contact hypersensitivity. Journal of Investigative Dermatology 2007 127 8 1956 1963 2-s2.0-34250792190 10.1038/sj.jid.5700819
106. Diefenbeck M., Nerlich A., Schneeberger S., Wagner F., Hofmann G. O., Allograft vasculopathy after allogeneic vascularized knee transplantation. Transplant International 2011 24 1 e1 e5 2-s2.0-78649999959 10.1111/j.1432-2277. 2010.01178.x
107. Kaufman C. L., Blair B., Murphy E., Breidenbach W. B., A new option for amputees: transplantation of the hand. Journal of Rehabilitation Research and Development 2009 46 3 395 404 2-s2.0-70349276001 10.1682/JRRD.2008.08.0108
108. Unadkat J. V., Schneeberger S., Horibe E. H., Goldbach C., Solari M. G., Washington K. M., Gorantla V. S., Cooper G. M., Thomson A. W., Andrew Lee W. P., Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. American Journal of Transplantation 2010 10 2 251 261 2-s2.0-75149140435 10.1111/j.1600-6143.2009. 02941.x
109. Kratz A., Campos-Neto A., Hanson M. S., Ruddle N. H., Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. Journal of Experimental Medicine 1996 183 4 1461 1472 2-s2.0-0029958867 10.1084/jem.183.4.1461
110. Gretz J. E., Anderson A. O., Shaw S., Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunological Reviews 1997 156 11 24 2-s2.0-0030944142
111. Drayton D. L., Liao S., Mounzer R. H., Ruddle N. H., Lymphoid organ development: from ontogeny to neogenesis. Nature Immunology 2006 7 4 344 353 2-s2.0-33645106845 10.1038/ni1330
112. Amft N., Curnow S. J., Scheel-Toellner D., Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis & Rheumatism 2001 44 11 2633 2641
113. Armengol M. P., Juan M., Lucas-Martín A., Fernández- Figueras M. T., Jaraquemada D., Gallart T., Pujol-Borrell R., Thyroid autoimmune disease: demonstration of thyroid antigen -specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. American Journal of Pathology 2001 159 3 861 873 2-s2.0-0034842962
114. Han S., Cao S., Bheekha-Escura R., Zheng B., Germinal center reaction in the joints of mice with collagen-induced arthritis: an animal model of lymphocyte activation and differentiation in arthritis joints. Arthritis & Rheumatism 2001 44 6 1438 1443
115. Kerjaschki D., Regele H. M., Moosberger I., Nagy-Bojarski K., Watschinger B., Soleiman A., Birner P., Krieger S., Hovorka A., Silberhumer G., Laakkonen P., Petrova T., Langer B., Raab I., Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Journal of the American Society of Nephrology 2004 15 3 603 612 2-s2.0-10744229023 10.1097/01.ASN.0000113316.52371.2E
116. Cupedo T., Jansen W., Kraal G., Mebius R. E., Induction of secondary and tertiary lymphoid structures in the skin. Immunity 2004 21 5 655 667 2-s2.0-8444243249 10.1016/j.immuni.2004.09.006
117. Nasr I. W., Reel M., Oberbarnscheidt M. H., Mounzer R. H., Baddoura F. K., Ruddle N. H., Lakkis F. G., Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. American Journal of Transplantation 2007 7 5 1071 1079 2-s2.0-34247342697 10.1111/j.1600-6143.2007. 01756.x
118. Thaunat O., Field A. C., Dai J., Louedec L., Patey N., Bloch M. F., Mandet C., Belair M. F., Bruneval P., Meilhac O., Bellon B., Joly E., Michel J. B., Nicoletti A., Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proceedings of the National Academy of Sciences of the United States of America 2005 102 41 14723 14728 2-s2.0-26844581521 10.1073/pnas.0507223102
119. Motallebzadeh R., Rehakova S., Conlon T. M., Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. The FASEB Journal 2012 26 1 51 62
120. Brown K., Sacks S. H., Wong W., Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. European Journal of Immunology 2011 41 1 89 96 2-s2.0-78650408306 10.1002/eji.201040759
121. Cendales L. C., Kanitakis J., Schneeberger S., Burns C., Ruiz P., Landin L., Remmelink M., Hewitt C. W., Landgren T., Lyons B., Drachenberg C. B., Solez K., Kirk A. D., Kleiner D. E., Racusen L., The Banff 2007 working classification of skin-containing composite tissue allograft pathology. American Journal of Transplantation 2008 8 7 1396 1400 2-s2.0-47249148415 10.1111/j.1600-6143.2008. 02243.x